- Home
- VRNA
VRNA
Verona Pharma plc
as 09-16-2025 4:00pm EST
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.
| Founded: | 2005 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 8.3B | IPO Year: | 2017 |
| Target Price: | $114.10 | AVG Volume (30 days): | 1.3M |
| Analyst Decision: | Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $27.54 - $106.45 | Next Earning Date: | 11-03-2025 |
| Revenue: | $221,673,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 896.59% | Revenue Growth (next year): | 77.56% |
Latest Verona Pharma plc News
VRNA Breaking Stock News: Dive into VRNA Ticker-Specific Updates for Smart Investing
Insider Monkey
a day ago
Verona Pharma (VRNA) Rebounded from Challenging Q1
GlobeNewswire
a day ago
Verona Pharma to Present Additional Analyses of the Phase 3 ENHANCE Studies in COPD at ERS International Congress 2025
Simply Wall St.
4 days ago
Does Verona Pharma's Recent FDA Approval Rally Signal Further Upside in 2025?
Insider Monkey
5 days ago
Here’s What Boosted Verona Pharma plc (VRNA) Share Price by 49%
TipRanks
3 months ago
Verona Pharma price target raised to $160 from $76 at Piper Sandler
Barchart
3 months ago
Up 515%, Watch This Biopharma Breakout
Insider Monkey
3 months ago
Jefferies Backs Verona Pharma plc (VRNA) After Strong Ohtuvayre Launch
Motley Fool
3 months ago
Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today
Compare VRNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRNA Verona Pharma plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.